Multiple Management Modalities in Esophageal Cancer: Combined Modality Management Approaches

Oncologist

Volumn 9, Issue 2, 2004, Pages 147-159

  Koshy, Mary ^a   Esiashvilli, Natia ^a   Landry, Jerome C ^a   Thomas Jr , Charles R ^b   Matthew, Richard H ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Esophageal carcinoma; Multimodal treatment; Survival

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; PACLITAXEL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DOSIMETRY; ESOPHAGUS CANCER; HUMAN; INTERMETHOD COMPARISON; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY;

EID: 1842452788     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.9-2-147     Document Type: Review

References (112)

1. Nakayama K, Orihata H, Yamaguchi K. Surgical treatment combined with preoperative concentrated irradiation for esophageal cancer. Cancer 1967;20:778-788.
2. Nygaard K, Hagen S, Hansen HS et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1109; discussion 1110.
3. Launois B, Delarue D, Campion JP et al. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153:690-692.
4. Gignoux M, Roussel A, Paillot B et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 1987;11:426-432.
5. Wang M, Gu XZ, Yin WB et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325-327.
6. Arnott SJ, Duncan W, Gignoux M et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998;41:579-583.
7. Arnott SJ, Duncan W, Kerr GR et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 1992;24:108-113.
8. Huang GJ, Gu XZ, Wang LJ et al. Combined preoperative radiation and surgery for esophageal carcinoma. In: Delarue NC, ed. International Trends in General Thoracic Surgery. St Louis, MO: C.V. Mosby, 1988:315.
9. Kasai M, Mori S, Watanabe T. Follow-up results after resection of thoracic esophageal carcinoma. World J Surg 1978;2:543-551.
10. Teniere P, Hay JM, Fingerhut A et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 1991;173:123-130.
11. Fok M, Sham JS, Choy D et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113:138-147.
12. Sun DR. Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 1989;16:329-334.
13. Okawa T, Kita M, Tanaka M et al. Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1989;17:49-54.
14. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
15. Araujo CM, Souhami L, Gil RA et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991;67:2258-2261.
16. Sykes AJ, Burt PA, Slevin NJ et al. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol 1998;48:15-21.
17. Wan J, Guo BZ, Gao SZ. Accelerated hyperfractionation radiotherapy in esophageal cancer. An analysis of 172 cases. Chin Med J (Engl) 1991;104:228-229.
18. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996;78:1820-1828.
19. Greene FL, Page DL, Fleming ID et al., eds. AJCC Cancer Staging Manual, Sixth Edition. New York: Springer, 2002:101-118.
20. Keane TJ, Harwood AR, Elhakim T et al. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol 1985;4:205-210.
21. John MJ, Flam MS, Mowry PA et al. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989;63:2397-2403.
22. Coia LR, Engstrom PF, Paul AR et al. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
23. Gill PG, Denham JW, Jamieson GG et al. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 1992;10:1037-1043.
24. Hatlevoll R, Hagen S, Hansen HS et al. Bleomycin/cisplatin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study: the second Scandinavian trial in esophageal cancer. Radiother Oncol 1992;24:114-116.
25. Smith TJ, Ryan LM, Douglass HO Jr et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:269-276.
26. Slabber CF, Nel JS, Schoeman L et al. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998;21:462-465.
27. al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997;15:277-284.
28. Cooper JS, Guo MD, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-1627.
29. Minsky BD, Neuberg D, Kelsen DP et al. Final report of Intergroup Trial 0122 (ECOG PE-289,RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999;43:517-523.
30. Minsky BD, Pajak TF, Ginsberg RJ et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-1174.
31. Agha FP, Gennis MA, Orringer MB et al. Evaluation of response to preoperative chemotherapy in esophageal and gastric cardia cancer using biphasic esophagrams and surgical-pathologic correlation. Am J Clin Oncol 1986;9:227-232.
32. Forastiere AA, Gennis M, Orringer MB et al. Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. J Clin Oncol 1987;5:1143-1149.
33. Schlag P, Herrmann R, Raeth V et al. Preoperative chemotherapy in esophageal cancer. A phase II study. Acta Oncol 1988;27:811-814.
34. Hilgenberg AD, Carey RW, Wilkins EW Jr et al. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988;45:357-363.
35. Kies MS, Rosen ST, Tsang TK et al. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 1987;60:2156-2160.
36. Carey RW, Hilgenberg AD, Choi NC et al. A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus. Cancer 1991;68:489-492.
37. Ajani JA, Roth JA, Ryan B et al. Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 1990;8:1231-1238.
38. Ajani JA, Ryan B, Rich TA et al. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer 1992;28A:880-884.
39. Ajani JA, Roth JA, Putnam JB et al. Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction. Eur J Cancer 1995;31A:665-670.
40. Imdahl A, Bognar G, Schulte-Monting J et al. Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer. Eur J Cardiothorac Surg 2002;21:657-663.
41. Archer VR, Mulholland PJ, Stocken DD et al. Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 2001;13:164-169.
42. Carey RW, Hilgenberg AD, Wilkins EW Jr et al. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 1993;11:99-105.
43. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999;94:3413-3419.
44. Tabira Y, Okuma T, Kondo K et al. Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity? Jpn J Thorac Cardiovasc Surg 1999;47:361-367.
45. Wang ZY. [Preoperative chemotherapy of esophageal cancer.] Zhonghua Zhong Liu Za Zhi 1986;8:61-63. Chinese.
46. Wang C, Ding T, Chang L. [A randomized clinical study of preoperative chemotherapy for esophageal carcinoma.] Zhonghua Zhong Liu Za Zhi 2001;23:254-255. Chinese.
47. Roth JA, Pass HI, Flanagan MM et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988;96:242-248.
48. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992;127:1446-1450.
49. Maipang T, Vasinanukorn P, Petpichetchian C et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994;56:191-197.
50. Law S, Fok M, Chow S et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210-217.
51. Kelsen DP, Ginsberg R, Pajak TF et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984.
52. Baba M, Natsugoe S, Shimada M et al. Does preoperative chemotherapy cause adverse effects on the perioperative course of patients undergoing esophagectomy for carcinoma? Jpn J Thorac Cardiovasc Surg 1999;47:199-203.
53. Ancona E, Ruol A, Santi S et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001;91:2165-2174.
54. Kok TC, van Lanschot J, Siersema PD et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997;16:227a.
55. Girling DJ, Clark PI. Randomized trials in the treatment of cancer of the esophagus. J Clin Oncol 1992;10:1031-1033.
56. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-1733.
57. Nesbitt J, Ajani JA, Komaki R et al. Preoperative taxol-based chemotherapy (CT) followed by chemoradiation therapy (CTRT) in patients (PTS) with potentially resectable esophageal carcinoma (EC). Proc Am Soc Clin Oncol 1998;17:282a.
58. Safran H, Gaissert H, Akerman P et al. Neoadjuvant paclitaxel, cisplatin and radiation for esophageal cancer. Proc Am Soc Clin Oncol 1998;17:259a.
59. Posner MC, Gooding WE, Landreneau RJ et al. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am 1998;4:237-246.
60. Shahab N, Wilkes J, Beyer S et al. Neoadjuvant chemoradiation followed by transhiatal esophagectomy for regional/locally advanced esophageal carcinoma. Proc Am Soc Clin Oncol 1996;17:259a.
61. Jones DR, Detterbeck FC, Egan TM et al. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997;64:185-191; discussion 191-192.
62. Leichman L, Steiger Z, Seydel HG et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 1984;2:75-79.
63. Poplin E, Fleming T, Leichman L et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987;5:622-628.
64. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990;8:119-127.
65. Urba SG, Orringer MB, Perez-Tamayo C et al. Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma. Cancer 1992;69:285-291.
66. Forastiere AA. Treatment of locoregional esophageal cancer. Semin Oncol 1992;19(suppl 11):57-63.
67. Heath EI, Burtness BA, Heitmiller RF et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000;18:868-876.
68. Ajani JA, Komaki R, Putnam JB et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 2001;92:279-286.
69. Slater MS, Holland J, Faigel DO et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001;181:440-444.
70. Laterza E, de'Manzoni G, Tedesco P et al. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase II study. Ann Surg Oncol 1999;6:777-784.
71. Forastiere AA, Heitmiller RF, Lee DJ et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am 1997;3:144-152.
72. Adelstein DJ, Rice TW, Becker M et al. Concurrent chemotherapy (CCT), accelerated fractionated radiation (AFR) and surgery for esophageal cancer. Proc Am Soc Clin Oncol 1996;15:203a.
73. Raoul JL, Le Prise E, Meunier B et al. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998;42:29-34.
74. Adelstein DJ, Rice TW, Becker M et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80:1011-1020.
75. Stahl M, Wilke H, Fink U et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 1996;14:829-837.
76. Nguyen NP, Leonardo JM, Karlsson U et al. Preoperative chemotherapy and radiation for advanced esophageal carcinoma: comparison between once a day radiation and hyperfractionation, a single-institution experience. Am J Clin Oncol 2002;25:358-364.
77. Bates BA, Detterbeck FC, Bernard SA et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996;14:156-163.
78. Gaspar LE, Winter K, Kocha WI et al. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer 2000;88:988-995.
79. Kavanagh B, Anscher M, Leopold K et al. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys 1992;24:633-642.
80. Coia L, Minsky B, John M et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care study. Proc Am Soc Clin Oncol 1998;17:258a.
81. Le Prise E, Etienne PL, Meunier B et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
82. Urba S, Orringer M, Turrisi A et al. A randomized trial comparing transhiatal esophagectomy (THE) to preoperative concurrent chemoradiation (CT/XRT) followed by esophagectomy in localregional esophageal carcinoma. Proc Am Soc Clin Oncol 1995;14:199a.
83. Urba S, Orringer M, Turrisi A et al. A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable esophageal cancer. Proc Am Soc Clin Oncol 1997;16:277a.
84. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
85. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
86. Ilson DH. New developments in the treatment of esophageal cancer. Curr Oncol Rep 2002;4:213-221.
87. Nozoe T, Saeki H, Ito S et al. Preoperative hyperthermochemoradiotherapy for esophageal carcinoma. Surgery 2002;131(suppl 1):S35-S38.
88. Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002;38:300-313.
89. Vermund H, Pories WJ, Hillard J et al. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer. Acta Oncol 2001;40:558-565.
90. Rich TA, Ajani JA. High dose external beam radiation therapy with or without concomitant chemotherapy for esophageal carcinoma. Ann Oncol 1994;5(suppl 3):9-15.
91. Kelsen D, Ilson D, Minsky B et al. Phase I trial of combined modality therapy for localized esophageal cancer: radiation therapy + concurrent cisplatin and escalating doses of 96 hour infusional paclitaxel. Proc Am Soc Clin Oncol 1998;17:260a.
92. Safran H, Akerman P, Cioffi W et al. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Semin Radiat Oncol 1999;9(suppl 1):53-57.
93. Ilson DH, Ajani J, Bhalla K et al. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998;16:1826-1834.
94. Kelsen D, Ilson D, Lipton R et al. A phase I trial of radiation therapy (RT) plus concurrent fixed dose cisplatin (C) with escalating doses of paclitaxel (P) as a 96 hour continuous infusion in patients (PTS) with localized esophageal cancer (EC). Proc Am Soc Clin Oncol 1999;18:271a.
95. van der Gaast A, Kok TC, Kerkhofs L et al. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer. Br J Cancer 1999;80:1052-1057.
96. van der Gaast A, Polee M, Kok TC et al. Phase I study with weekly cisplatin and increasing doses of paclitaxel in patients with esophageal cancer. Proc Am Soc Clin Oncol 1999;18:303a.
97. Philip PA, Zalupski MM, Gadgeel S et al. A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer. Semin Oncol 1997;24(suppl 19):S19-86-S19-88.
98. Goldberg M, Lampert C, Colarusso P et al. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil and radiation in resectable esophageal carcinoma: a phase I report [abstract]. http://www.asco.org/ac/1,1003,_12-002489-00_18-002002-00_19-00612,00.asp, accessed 01/11/03.
99. Bains MS, Stojadinovic A, Minsky B et al. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. J Thorac Cardiovasc Surg 2002;124:270-277.
100. Kelsen D, Lovett D, Wong J et al. Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer. J Clin Oncol 1992;10:269-274.
101. Wadler S, Fell S, Haynes H et al. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon. Cancer 1993;71:1726-1730.
102. Ilson DH, Sirott M, Saltz L et al. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer 1995;75:2197-2202.
103. Enzinger PC, Ilson DH, Saltz LB et al. Irinotecan and cisplatin in upper gastrointestinal malignancies. Oncology (Huntingt) 1998;12(suppl 6):110-113.
104. Ilson DH, Saltz L, Enzinger P et al. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 1999;17:3270-3275.
105. Ajani J, Fairweather J, Pisters P et al. U.T.M.D Anderson Center: phase II study of CPT-11 plus cisplatin in patients with advanced gastric and GE junction carcinomas. Proc Am Soc Clin Oncol 1999;18:241a.
106. Anderson S, Ilson D, Bains M et al. Phase I trial of cisplatin and escalating dose irinotecan given weekly with concurrent radiation in locally advanced esophageal cancer [abstract]. http://www.asco.org/ac/1,1003,_12-002489-00_18-002001-00_19-00629,00.asp, accessed 1/11/03.
107. Kolaric K, Maricic Z, Dujmovic I et al. Therapy of advanced esophageal cancer with bleomycin, irradiation and combination of bleomycin with irradiation. Tumori 1976;62:255-262.
108. Roussel A, Bleiberg H, Dalesio O et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys 1989;16:67-72.
109. Roussel A, Haegele P, Paillot B et al. Results of the EORTC-GTCCG Phase III trial of irradiation vs irradiation and CDDP in inoperable esophageal cancer. Proc Am Soc Clin Oncol 1994;13:30.
110. Earle JD, Gelber RD, Moertel CG et al. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1980;6:821-826.
111. Khushalani NI, Leichman CG, Proulx G et al. Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 2002;20:2844-2850.
112. Koshy M, Esiashvilli N, Landry JC et al. Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, workup, and surgical approaches. The Oncologist 2004;9:137-146.